Skip to main content

Table 3 Incidence of dementia estimated by comorbidity for CKD and non-CKD cohorts

From: Patients with chronic kidney disease are at an elevated risk of dementia: A population-based cohort study in Taiwan

 

Non-CKD

CKD

 

Comorbidity

Case

Incidence rate†

Case

Incidence rate†

HR

(95% CI)

Hypertension

No

995

3.01

337

3.48

1.64

(1.45-1.86)

Yes

1626

11.5

1676

14.02

1.48

(1.38-1.58)

Diabetes mellitus

No

2212

5.08

1203

7.83

1.52

(1.42-1.64)

Yes

409

11.2

810

12.9

1.42

(1.26-1.60)

Ischemic heart disease

No

1680

4.23

921

6.05

1.63

(1.50-1.76)

Yes

941

12.5

1092

17.0

1.52

(1.39-1.65)

Hyperlipidemia

No

2286

5.33

1491

9.36

1.65

(1.54-1.78)

Yes

335

7.78

522

9.14

1.43

(1.25-1.64)

Tobacco use disorder

No

2620

5.55

2007

9.30

1.60

(1.51-1.70)

Yes

1

1.81

6

11.1

6.73

(0.81-56.1)

Alcoholism

No

2608

5.54

1992

9.27

1.60

(1.50-1.69)

Yes

13

8.72

21

14.8

2.88

(1.41-5.91)

Obesity

No

2614

5.56

2001

9.34

1.60

(1.51-1.70)

Yes

7

3.13

12

5.32

2.81

(1.04-7.58)

Atrial fibrillation

No

2562

5.46

1929

9.03

1.59

(1.50-1.69)

Yes

59

19.2

84

29.9

1.67

(1.19-2.33)

Parkinson's disease

No

2482

5.30

1876

8.78

1.61

(1.51-1.71)

Yes

139

38.0

137

50.9

1.30

(1.02-1.65)

Cerebrovascular disease

No

1701

4.01

1048

5.89

1.59

(1.47-1.72)

Yea

920

19.2

965

25.1

1.41

(1.28-1.54)

Major depressive disorder

No

2546

5.44

1949

9.15

1.61

(1.51-1.71)

Yes

75

16.5

64

18.8

1.44

(1.03-2.03)

  1. † Incidence rate: per 1,000 person-years.
  2. HR: CKD vs. non-CKD (95% CI), adjsued for age, sex, use of benzodiazepine, aspirin, other NSAIDs and COX2.